CONSOLIDATED STATEMENTS OF CHANGES IN SERIES B CNVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Total
Series B Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Balance at Jul. 31, 2013 $ 374,343 $ 262,475 $ 7,050 $ 86,449 $ 11,229,864 $ (10,949,020)
Balance (Shares) at Jul. 31, 2013   262,475 7,050,000 10,806,520    
Stock-based compensation 39,382       39,382 0
Common shares issued to consultants 50,000     $ 2,000 48,000 0
Common shares issued to consultants (in shares)       250,000    
Common shares issued to advisory board 47,000     $ 2,000 45,000 0
Common shares issued to advisory board (in shares)       250,000    
Series A convertible preferred stock issued 0   $ 2,950   (2,950) 0
Series A convertible preferred stock issued (In shares)     2,950,000      
Annual 6% common stock dividend for preferred shareholders per Series B agreement 0     $ 126 3,499 (3,625)
Annual 6% common stock dividend for preferred shareholders per Series B agreement (in shares)       15,760    
Common shares issued in connection with equity financing 75,000     $ 3,435 71,565 0
Common shares issued in connection with equity financing (in shares)       429,332    
Common shares issued in connection with asset acquisition 5,198,375     $ 115,284 5,083,091 0
Common shares issued in connection with asset acquisition (in shares)       14,410,481    
Net loss for the year (467,751)         (467,751)
Balance at Jul. 31, 2014 5,316,349 $ 262,475 $ 10,000 $ 209,294 16,517,451 (11,420,396)
Balance (in shares) at Jul. 31, 2014   262,475 10,000,000 26,162,093    
Stock-based compensation 366,395       366,395 0
Common shares issued to consultants 468,400     $ 26,408 441,992  
Common shares issued to consultants (in shares)       3,300,975    
Common shares issued to advisory board 280,000     $ 16,000 264,000 0
Common shares issued to advisory board (in shares)       2,000,000    
Annual 6% common stock dividend for preferred shareholders per Series B agreement 0     $ 126 1,765 (1,891)
Annual 6% common stock dividend for preferred shareholders per Series B agreement (in shares)       15,760    
Common shares issued in connection with equity financing 127,499     $ 11,808 115,691 0
Common shares issued in connection with equity financing (in shares)       1,475,953    
Issuance of common stock to an investor as a commitment fee 95,000     $ 4,000 91,000  
Issuance of common stock to an investor as a commitment fee (in shares)       500,000    
Issuance of common stock in connection with convertible debt 137,000     $ 5,600 131,400  
Issuance of common stock in connection with convertible debt (in shares)       700,000    
Conversion of note payable to common stock 65,000     $ 14,461 50,539 0
Conversion of note payable to common stock (in shares)       1,807,579    
Conversion of Series A convertible preferred stock into common stock 0   $ (10,000) $ 160,000 (150,000) 0
Conversion of Series A convertible preferred stock into common stock (in shares)     (10,000,000) 20,000,000    
Common stock issued to employees 4,780     $ 294 4,486 0
Common stock issued to employees (in shares)       36,758    
Net loss for the year (4,157,835)         (4,157,835)
Balance at Jul. 31, 2015 $ 2,702,588 $ 262,475 $ 0 $ 447,991 $ 17,834,719 $ (15,580,122)
Balance (in shares) at Jul. 31, 2015   262,475 0 55,999,118